UniProt P27958
P27958
P27958 (UniProt P27958): 54 experimental structures on GenesisL1, 1 ligand bound. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P27958
- Experimental structures
- 54
- Predicted models
- 0
- Ligands
- 1
Structures
54 records of P27958 in the MolNFT archive: 54 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1A1R | HCV NS3 protease DOMAIN:NS4A peptide complex | x-ray diffraction | A, B, C, D | — | — |
| 1A1R | HCV NS3 protease DOMAIN:NS4A peptide complex | x-ray diffraction | A, B, C, D | — | — |
| 1A1V | Hepatitis C virus NS3 helicase domain complexed with single stranded sdna | x-ray diffraction | A | — | — |
| 1A1V | Hepatitis C virus NS3 helicase domain complexed with single stranded sdna | x-ray diffraction | A | — | — |
| 1CWX | Solution structure of the hepatitis C virus N-terminal capsid protein 2-45 [C-HCV(2-45)] | solution nmr | A | — | — |
| 1CWX | Solution structure of the hepatitis C virus N-terminal capsid protein 2-45 [C-HCV(2-45)] | solution nmr | A | — | — |
| 1HEI | Structure of the hepatitis C virus RNA helicase domain | x-ray diffraction | A, B | — | — |
| 1HEI | Structure of the hepatitis C virus RNA helicase domain | x-ray diffraction | A, B | — | — |
| 1JR6 | Solution Structure of an Engineered Arginine-rich Subdomain 2 of the Hepatitis C Virus NS3 RNA… | solution nmr | A | — | — |
| 1JR6 | Solution structure of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA… | solution nmr | A | — | — |
| 1N1L | Crystal structure of HCV NS3 protease DOMAIN:NS4A peptide complex with covalently bound inhibitor… | x-ray diffraction | A, B | — | — |
| 1N1L | Crystal structure of HCV NS3 protease DOMAIN:NS4A peptide complex with covalently bound inhibitor… | x-ray diffraction | A, B | — | — |
| 1ONB | Solution structure of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA… | solution nmr | A | — | — |
| 1ONB | Solution structure of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA… | solution nmr | A | — | — |
| 1R7C | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7C | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7D | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7D | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7E | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7E | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7F | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7F | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7G | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1R7G | NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of… | solution nmr | A | — | — |
| 1RGQ | M9A HCV Protease complex with pentapeptide keto-amide inhibitor | x-ray diffraction | A, B | — | — |
| 1RGQ | M9A HCV protease complex with pentapeptide keto-amide inhibitor | x-ray diffraction | A, B | — | — |
| 2HD0 | Structure of the catalytic domain of hepatitis C virus NS2 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 2HD0 | Structure of the catalytic domain of hepatitis C virus NS2 | x-ray diffraction | A, B, C, D, E, F, G, H, I, J, K, L | — | — |
| 2JXF | The solution structure of HCV NS4B(40-69) | solution nmr | A | — | — |
| 2JXF | The solution structure of HCV NS4B(40-69) | solution nmr | A | — | — |
| 2KDR | Solution structure of HCV NS4B(227-254) | solution nmr | X | — | — |
| 2KDR | Solution structure of HCV NS4B(227-254) | solution nmr | X | — | — |
| 2N1P | Structure of the C-terminal membrane domain of HCV NS5B protein | solution nmr | A | — | — |
| 2N1P | Structure of the C-terminal membrane domain of HCV NS5B protein | solution nmr | A | — | — |
| 2O8M | Crystal structure of the S139A mutant of Hepatitis C Virus NS3/4A protease | x-ray diffraction | C, D | — | — |
| 2O8M | Crystal structure of the S139A mutant of hepatitis C virus NS3/4A protease | x-ray diffraction | C, D | — | — |
| 2OBQ | Discovery of the HCV NS3/4A Protease Inhibitor SCH503034. Key Steps in Structure-Based Optimization | x-ray diffraction | B, D | — | — |
| 2OBQ | Discovery of the HCV NS3/4A protease inhibitor SCH503034. key steps in structure-based optimization | x-ray diffraction | B, D | — | — |
| 2XI2 | HCV-H77 NS5B Apo Polymerase | x-ray diffraction | A, B, C | — | — |
| 2XI2 | HCV-H77 NS5B apo polymerase | x-ray diffraction | A, B, C | — | — |
| 2XI3 | HCV-H77 NS5B Polymerase Complexed With GTP | x-ray diffraction | A, B | — | — |
| 2XI3 | HCV-H77 NS5B polymerase complexed with GTP | x-ray diffraction | A, B | — | — |
| 4JZN | Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV)… | x-ray diffraction | K | — | — |
| 4JZN | Three dimensional structure of broadly neutralizing human anti - hepatitis C virus (HCV)… | x-ray diffraction | K | — | — |
| 4JZO | Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV)… | x-ray diffraction | I, J, K, L | — | — |
| 4JZO | Three dimensional structure of broadly neutralizing human anti - hepatitis C virus (HCV)… | x-ray diffraction | I, J, K, L | — | — |
| 4MWF | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core bound to broadly neutralizing antibody… | x-ray diffraction | C, D | — | — |
| 4MWF | Structure of hepatitis C virus envelope glycoprotein E2 core bound to broadly neutralizing antibody… | x-ray diffraction | C, D | — | — |
| 4Q0X | Crystal structure of non-neutralizing antibody in complex with Epitope II of HCV E2 | x-ray diffraction | E | — | — |
| 4Q0X | Crystal structure of non-neutralizing antibody in complex with epitope II of HCV E2 | x-ray diffraction | E | — | — |
| 5FGB | Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV)… | x-ray diffraction | F, G | SO4 | — |
| 5FGB | Three dimensional structure of broadly neutralizing human anti - hepatitis C virus (HCV)… | x-ray diffraction | F, G | — | — |
| 5FGC | Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV)… | x-ray diffraction | A | — | — |
| 5FGC | Three dimensional structure of broadly neutralizing human anti - hepatitis C virus (HCV)… | x-ray diffraction | A | — | — |
Ligands
- SO4 · Sulfate ion · in 1 record
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.